D(
Therapeutic Areas
InterCure Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Canndoc Product Portfolio | Chronic Pain, Chemotherapy-Induced Nausea & Vomiting, PTSD, Crohn's Disease, Parkinson's Disease, and other approved conditions | Approved |
Leadership Team at InterCure
A(
Alexander (Sasha) Rabinovich
Interim Chief Executive Officer and Director
AC
Amos Cohen
Chief Financial Officer
TG
Talia Garon
Chief Regulatory & Quality Officer
NB
Nissim Bracha
Chief Operating Officer
DY
Dr. Yaron Biala
Chief Medical Officer
PR
Prof. Raphael Mechoulam
Scientific Advisor / Honorary Director